Roche

positive negative up down good bad mixed
Biotech

Roche heads to FDA as eye disease trials yield mixed data

Roche is forging ahead with plans to seek approval for an eye disease candidate despite missing the primary endpoint in one of its phase 3 trials.
Nick Paul Taylor Oct 20, 2025 9:28am
Roche ESMO

ESMO: Roche wants oral SERD to benefit 'all comers'

Oct 18, 2025 1:00am
graphic art of a right hand signing something

Hansoh, Chugai ink separate and lucrative licensing agreements

Oct 17, 2025 11:04am
ChatGPT said Low-poly magenta liver model centered on a pale blue background patterned with sketchy dollar signs suggestin
Favicon Fierce Pharma

Big Pharma bets big on MASH with a new combo playbook

Oct 17, 2025 9:30am
Alzheimers research brain scientist magnifying glass questions neuro

Roche nabs FDA clearance for Alzheimer's biomarker blood test

Oct 14, 2025 11:12am
three triple doors opportunity cracked open ajar

89bio was left between a Roche and a hard place in buyout talks

Oct 2, 2025 9:55am